Latest filing published 08 Dec 2017 for AGIOS PHARMACEUTICALS, INC., €27k.
Filing timeline
BuySaleInsider track record
Lewis Clayton Cantley Jr.: trading record in brief
Lewis Clayton Cantley Jr. is a declared insider of Agios Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 144 filings cover trades dated from 15 December 2014 to 7 December 2017.
The open-market record consists of 142 sales worth €11.5M, with no purchase. So far in 2017, the count stands at no purchases and 58 sales.
On 8 December 2017 came the latest disclosure, an open-market sale for €10k in Agios Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lewis Clayton Cantley Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 543 shares@ US$57.901.0% of flowCommon stockSEC:0001209191-17-064704:0
- 542 shares@ US$57.901.0% of flowCommon stockSEC:0001209191-17-064704:1
- 253 shares@ US$58.950.5% of flowCommon stockSEC:0001209191-17-064704:2
- 254 shares@ US$58.950.5% of flowCommon stockSEC:0001209191-17-064704:3
- 204 shares@ US$60.010.4% of flowCommon stockSEC:0001209191-17-064704:4
- 288 shares@ US$59.680.6% of flowCommon stockSEC:0001209191-17-064704:6
- 631 shares@ US$60.451.3% of flowCommon stockSEC:0001209191-17-064704:8
- 1,000 shares@ US$62.072.1% of flowCommon stockSEC:0001209191-17-060967:0
- 691 shares@ US$59.361.4% of flowCommon stockSEC:0001209191-17-060967:2
- 309 shares@ US$60.460.6% of flowCommon stockSEC:0001209191-17-060967:4
- 1,000 shares@ US$71.092.3% of flowCommon stockSEC:0001209191-17-057318:0
- 1,000 shares@ US$71.102.3% of flowCommon stockSEC:0001209191-17-057318:2
- 1,000 shares@ US$65.472.1% of flowCommon stockSEC:0001209191-17-053010:0
- 1,000 shares@ US$65.712.1% of flowCommon stockSEC:0001209191-17-053010:2
- 500 shares@ US$56.630.9% of flowCommon stockSEC:0001209191-17-050096:0
- 500 shares@ US$56.610.9% of flowCommon stockSEC:0001209191-17-050096:2
- 500 shares@ US$57.090.9% of flowCommon stockSEC:0001209191-17-050096:4
- 500 shares@ US$57.070.9% of flowCommon stockSEC:0001209191-17-050096:6
- 3,000 shares@ US$56.155.7% of flowCommon stockSEC:0001209191-17-045921:0
- 500 shares@ US$56.110.9% of flowCommon stockSEC:0001209191-17-045921:2
- 500 shares@ US$57.121.0% of flowCommon stockSEC:0001209191-17-045921:4
- 500 shares@ US$57.131.0% of flowCommon stockSEC:0001209191-17-045921:6
- 500 shares@ US$51.090.9% of flowCommon stockSEC:0001209191-17-040187:2
- 500 shares@ US$50.640.9% of flowCommon stockSEC:0001209191-17-040187:0
- 509 shares@ US$47.270.8% of flowCommon stockSEC:0001209191-17-035585:0
25 of 113 declarations
